{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:31:20Z","timestamp":1788845480333,"version":"build-2803163510"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015705","name":"Center of Regenerative Medicine, Washington University in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015705","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG15768"],"award-info":[{"award-number":["AG15768"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG46927"],"award-info":[{"award-number":["AG46927"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR069588"],"award-info":[{"award-number":["AR069588"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR070975"],"award-info":[{"award-number":["AR070975"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR072999"],"award-info":[{"award-number":["AR072999"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR073752"],"award-info":[{"award-number":["AR073752"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR074992"],"award-info":[{"award-number":["AR074992"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR077678"],"award-info":[{"award-number":["AR077678"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR74240"],"award-info":[{"award-number":["AR74240"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR76665"],"award-info":[{"award-number":["AR76665"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DK007120"],"award-info":[{"award-number":["T32DK007120"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DK108742"],"award-info":[{"award-number":["T32DK108742"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000980","name":"Arthritis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011781","name":"Shriners Hospitals for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.actbio.2021.03.062","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T03:35:26Z","timestamp":1617420926000},"page":"74-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Immunoengineering the next generation of arthritis therapies"],"prefix":"10.1016","volume":"133","author":[{"given":"Molly","family":"Klimak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0856-3188","authenticated-orcid":false,"given":"Robert J.","family":"Nims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1968-3636","authenticated-orcid":false,"given":"Lara","family":"Pferdehirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey H.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia S.","family":"Harasymowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5292-2117","authenticated-orcid":false,"given":"Sara J.","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5992-4206","authenticated-orcid":false,"given":"Lori A.","family":"Setton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7380-0330","authenticated-orcid":false,"given":"Farshid","family":"Guilak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"51\u201352","key":"10.1016\/j.actbio.2021.03.062_bib0001","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.15585\/mmwr.mm665152a2","article-title":"Health care provider counseling for physical activity or exercise among adults with arthritis - United States, 2002 and 2014","volume":"66","author":"Hootman","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"9","key":"10.1016\/j.actbio.2021.03.062_bib0002","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.NPR.0000544281.05010.86","article-title":"Osteoarthritis treatment: decreasing pain, improving mobility","volume":"43","author":"Saccomano","year":"2018","journal-title":"Nurse Pract."},{"issue":"1","key":"10.1016\/j.actbio.2021.03.062_bib0003","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2017.08.003","article-title":"Genetic and environmental risk factors for rheumatoid arthritis","volume":"31","author":"Deane","year":"2017","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.actbio.2021.03.062_bib0004","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.3390\/ijms16036093","article-title":"Osteoarthritis in the XXIst century: risk factors and behaviours that influence disease onset and progression","volume":"16","author":"Musumeci","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.actbio.2021.03.062_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/biology9080194","article-title":"Pathogenesis of osteoarthritis: risk factors, regulatory pathways in chondrocytes, and experimental models","volume":"9","author":"He","year":"2020","journal-title":"Biology"},{"issue":"6","key":"10.1016\/j.actbio.2021.03.062_bib0006","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar4405","article-title":"Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes","volume":"15","author":"Li","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.actbio.2021.03.062_bib0007","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-016-0604-x","article-title":"The role of MicroRNAs and their targets in osteoarthritis","volume":"18","author":"Sondag","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"issue":"8","key":"10.1016\/j.actbio.2021.03.062_bib0008","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.joca.2009.03.002","article-title":"Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix","volume":"17","author":"Loeser","year":"2009","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"10.1016\/j.actbio.2021.03.062_bib0009","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jor.24457","article-title":"Role of inflammation and the immune system in the progression of osteoarthritis","volume":"38","author":"Woodell-May","year":"2020","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.actbio.2021.03.062_bib0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.coph.2015.03.004","article-title":"Emerging targets in osteoarthritis therapy","volume":"22","author":"Goldring","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.actbio.2021.03.062_bib0011","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/ar2292","article-title":"Cells of the synovium in rheumatoid arthritis","volume":"9","author":"Otero","year":"2007","journal-title":"Chondrocytes, Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.actbio.2021.03.062_bib0012","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3831\/KPI.2019.22.029","article-title":"Rheumatiod arthritis: an updated overview of latest therapy and drug delivery","volume":"22","author":"Kesharwani","year":"2019","journal-title":"J. Pharmacopunct."},{"issue":"5","key":"10.1016\/j.actbio.2021.03.062_bib0013","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/ard.2009.121657","article-title":"Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis","volume":"69","author":"Schett","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.actbio.2021.03.062_bib0014","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/art.40504","article-title":"Review: synovial cell metabolism and chronic inflammation in rheumatoid arthritis","volume":"70","author":"Falconer","year":"2018","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.actbio.2021.03.062_bib0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/1759720X10378373","article-title":"The role of synovitis in osteoarthritis","volume":"2","author":"Wenham","year":"2010","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"2","key":"10.1016\/j.actbio.2021.03.062_bib0016","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"issue":"7771","key":"10.1016\/j.actbio.2021.03.062_bib0017","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41586-019-1471-1","article-title":"Locally renewing resident synovial macrophages provide a protective barrier for the joint","volume":"572","author":"Culemann","year":"2019","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.actbio.2021.03.062_bib0018","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.actbio.2021.03.062_bib0019","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cytogfr.2019.03.004","article-title":"Clinical implications of macrophage dysfunction in the development of osteoarthritis of the knee","volume":"46","author":"Xie","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"issue":"12","key":"10.1016\/j.actbio.2021.03.062_bib0020","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.joca.2012.08.027","article-title":"Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review","volume":"20","author":"de Lange-Brokaar","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"10.1016\/j.actbio.2021.03.062_bib0021","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cyto.2014.10.006","article-title":"The role of the Th17 cytokines IL-17 and IL-22 in rheumatoid arthritis pathogenesis and developments in cytokine immunotherapy","volume":"74","author":"Roeleveld","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.actbio.2021.03.062_bib0022","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.intimp.2018.12.040","article-title":"Study of the adoptive immunotherapy on rheumatoid arthritis with Thymus-derived invariant natural killer T cells","volume":"67","author":"Chen","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.actbio.2021.03.062_bib0023","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cyto.2014.06.019","article-title":"Osteoarthritis joint pain: the cytokine connection","volume":"70","author":"Miller","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.actbio.2021.03.062_bib0024","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.imlet.2016.05.001","article-title":"IL-17+ CD8+ T cells: differentiation, phenotype and role in inflammatory disease","volume":"178","author":"Srenathan","year":"2016","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.actbio.2021.03.062_bib0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s13770-019-00204-z","article-title":"The interaction between joint inflammation and cartilage repair","volume":"16","author":"van der Kraan","year":"2019","journal-title":"Tissue Eng. Regen. Med."},{"issue":"1","key":"10.1016\/j.actbio.2021.03.062_bib0026","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cei.13098","article-title":"Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells","volume":"193","author":"Alivernini","year":"2018","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.actbio.2021.03.062_bib0027","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/art.1780330602","article-title":"How important are T cells in chronic rheumatoid synovitis?","volume":"33","author":"Firestein","year":"1990","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.actbio.2021.03.062_bib0028","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.joca.2017.02.791","article-title":"ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the 'usual suspects","volume":"25","author":"Yang","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"issue":"3","key":"10.1016\/j.actbio.2021.03.062_bib0029","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clim.2012.12.011","article-title":"Immunopathogenesis of osteoarthritis","volume":"146","author":"Haseeb","year":"2013","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.actbio.2021.03.062_bib0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","article-title":"Role of proinflammatory cytokines in the pathophysiology of osteoarthritis","volume":"7","author":"Kapoor","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.actbio.2021.03.062_bib0031","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.3389\/fimmu.2019.02759","article-title":"More than just attractive: how CCL2 influences myeloid cell behavior beyond chemotaxis","volume":"10","author":"Gschwandtner","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2021.03.062_bib0032","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3389\/fimmu.2019.01146","article-title":"Ontogeny of synovial macrophages and the roles of synovial macrophages from different origins in arthritis","volume":"10","author":"Tu","year":"2019","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.actbio.2021.03.062_bib0033","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1016\/S2665-9913(20)30279-4","article-title":"Of mice and men: converging on a common molecular understanding of osteoarthritis","volume":"2","author":"Vincent","year":"2020","journal-title":"Lancet Rheumatol."},{"issue":"2","key":"10.1016\/j.actbio.2021.03.062_bib0034","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.rdc.2010.03.004","article-title":"Innate immunity and rheumatoid arthritis","volume":"36","author":"Gierut","year":"2010","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"4","key":"10.1016\/j.actbio.2021.03.062_bib0035","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.actbio.2021.03.062_bib0036","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1474-9726.2008.00399.x","article-title":"Stem cell review series: aging of the skeletal muscle stem cell niche","volume":"7","author":"Gopinath","year":"2008","journal-title":"Aging Cell"},{"key":"10.1016\/j.actbio.2021.03.062_bib0037","doi-asserted-by":"crossref","first-page":"124","DOI":"10.22203\/eCM.v029a10","article-title":"Sustained intra-articular delivery of IL-1RA from a thermally-responsive elastin-like polypeptide as a therapy for post-traumatic arthritis","volume":"29","author":"Kimmerling","year":"2015","journal-title":"Eur. Cell Mater."},{"issue":"4","key":"10.1016\/j.actbio.2021.03.062_bib0038","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.biocel.2008.08.033","article-title":"Regenerative pharmacology in the treatment of genetic diseases: the paradigm of muscular dystrophy","volume":"41","author":"Mozzetta","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.actbio.2021.03.062_bib0039","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrrheum.2014.162","article-title":"Emerging regulators of the inflammatory process in osteoarthritis","volume":"11","author":"Liu-Bryan","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"issue":"10","key":"10.1016\/j.actbio.2021.03.062_bib0040","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.joca.2018.05.021","article-title":"Disease-modifying effects of COX-2 selective inhibitors and non-selective NSAIDs in osteoarthritis: a systematic review","volume":"26","author":"Nakata","year":"2018","journal-title":"Osteoarthritis Cartilage"},{"issue":"7134","key":"10.1016\/j.actbio.2021.03.062_bib0041","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/bmj.316.7134.789","article-title":"Corticosteroids in rheumatoid arthritis","volume":"316","author":"Dennison","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.actbio.2021.03.062_bib0042","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.biomaterials.2015.02.109","article-title":"Sustained intra-articular release of celecoxib from in situ forming gels made of acetyl-capped PCLA-PEG-PCLA triblock copolymers in horses","volume":"53","author":"Petit","year":"2015","journal-title":"Biomaterials"},{"issue":"423","key":"10.1016\/j.actbio.2021.03.062_bib0043","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.blo.0000131233.83640.91","article-title":"The role of biomechanics and inflammation in cartilage injury and repair","author":"Guilak","year":"2004","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"7","key":"10.1016\/j.actbio.2021.03.062_bib0044","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1517\/13543776.18.7.723","article-title":"The development of novel therapies for rheumatoid arthritis","volume":"18","author":"Quan","year":"2008","journal-title":"Expert Opin. Ther. Pat."},{"issue":"4","key":"10.1016\/j.actbio.2021.03.062_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040880","article-title":"Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.actbio.2021.03.062_bib0046","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1759720X17712695","article-title":"Effectiveness of intra-articular therapies in osteoarthritis: a literature review","volume":"9","author":"Wehling","year":"2017","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.actbio.2021.03.062_bib0047","doi-asserted-by":"crossref","DOI":"10.1177\/1179544117723611","article-title":"The disease-modifying effects of hyaluronan in the osteoarthritic disease state","volume":"10","author":"Nicholls","year":"2017","journal-title":"Clin. Med. Insights Arthritis Musculoskelet. Disord."},{"issue":"3","key":"10.1016\/j.actbio.2021.03.062_bib0048","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrrheum.2013.8","article-title":"The problem of choice: current biologic agents and future prospects in RA","volume":"9","author":"Choy","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.actbio.2021.03.062_bib0049","doi-asserted-by":"crossref","first-page":"R134","DOI":"10.1186\/ar4591","article-title":"Targeting pro-inflammatory cytokines following joint injury: acute intra-articular inhibition of interleukin-1 following knee injury prevents post-traumatic arthritis","volume":"16","author":"Furman","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.actbio.2021.03.062_bib0050","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/art.24096","article-title":"Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study","volume":"61","author":"Chevalier","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.actbio.2021.03.062_bib0051","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jconrel.2016.01.026","article-title":"Delivery strategies to control inflammatory response: modulating M1-M2 polarization in tissue engineering applications","volume":"240","author":"Alvarez","year":"2016","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.actbio.2021.03.062_bib0052","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4103\/1735-5362.272534","article-title":"Receptor targeting drug delivery strategies and prospects in the treatment of rheumatoid arthritis","volume":"14","author":"Emami","year":"2019","journal-title":"Res. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.actbio.2021.03.062_bib0053","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/hum.2008.075","article-title":"Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis","volume":"20","author":"Wehling","year":"2009","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.actbio.2021.03.062_bib0054","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/hum.2017.181","article-title":"Gene delivery to joints by intra-articular injection","volume":"29","author":"Evans","year":"2018","journal-title":"Hum. Gene Ther."},{"issue":"24","key":"10.1016\/j.actbio.2021.03.062_bib0055","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1073\/pnas.0502854102","article-title":"Gene transfer to human joints: progress toward a gene therapy of arthritis","volume":"102","author":"Evans","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.actbio.2021.03.062_bib0056","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/14740338.2018.1486819","article-title":"Anakinra for the treatment of rheumatoid arthritis: a safety evaluation","volume":"17","author":"Ramirez","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"issue":"4","key":"10.1016\/j.actbio.2021.03.062_bib0057","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/ard.2006.053272","article-title":"Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade","volume":"65","author":"Grunke","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.actbio.2021.03.062_bib0058","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00296-009-0872-0","article-title":"Treatment of erosive osteoarthritis of the hands by intra-articular infliximab injections: a pilot study","volume":"29","author":"Fioravanti","year":"2009","journal-title":"Rheumatol. Int."},{"issue":"12","key":"10.1016\/j.actbio.2021.03.062_bib0059","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/annrheumdis-2018-213202","article-title":"Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"77","author":"Kloppenburg","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.actbio.2021.03.062_bib0060","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jama.2016.13512","article-title":"Non-TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical trial","volume":"316","author":"Gottenberg","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.actbio.2021.03.062_bib0061","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/14728214.2011.576670","article-title":"Emerging drugs for osteoarthritis","volume":"16","author":"Matthews","year":"2011","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"8","key":"10.1016\/j.actbio.2021.03.062_bib0062","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2106\/JBJS.17.00154","article-title":"Effects of a single intra-articular injection of a microsphere formulation of triamcinolone acetonide on knee osteoarthritis pain: a double-blinded, randomized, placebo-controlled, multinational study","volume":"100","author":"Conaghan","year":"2018","journal-title":"J. Bone Joint Surg. Am."},{"issue":"4","key":"10.1016\/j.actbio.2021.03.062_bib0063","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/0885328214535958","article-title":"In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes","volume":"29","author":"Erdemli","year":"2014","journal-title":"J. Biomater. Appl."},{"issue":"1","key":"10.1016\/j.actbio.2021.03.062_bib0064","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/10717544.2019.1710623","article-title":"OCTN2-targeted nanoparticles for oral delivery of paclitaxel: differential impact of the polyethylene glycol linker size on drug delivery in vitro, in situ, and in vivo","volume":"27","author":"Kou","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.actbio.2021.03.062_bib0065","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2020.07.005","article-title":"Targeting interleukin-4 to the arthritic joint","volume":"326","author":"Spieler","year":"2020","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.actbio.2021.03.062_bib0066","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/rb\/rbz013","article-title":"Injectable mechanical pillows for attenuation of load-induced post-traumatic osteoarthritis","volume":"6","author":"Holyoak","year":"2019","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.actbio.2021.03.062_bib0067","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.2147\/IJN.S140992","article-title":"Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis","volume":"12","author":"Zhao","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"10.1016\/j.actbio.2021.03.062_bib0068","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1177\/0363546510369547","article-title":"Scaffold-guided subchondral bone repair: implication of neutrophils and alternatively activated arginase-1+ macrophages","volume":"38","author":"Hoemann","year":"2010","journal-title":"Am. J. Sports Med."},{"issue":"3","key":"10.1016\/j.actbio.2021.03.062_bib0069","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00167-018-5079-z","article-title":"Clinical and radiographic outcomes of chitosan-glycerol phosphate\/blood implant are similar with hyaluronic acid-based cell-free scaffold in the treatment of focal osteochondral lesions of the knee joint","volume":"27","author":"Sofu","year":"2019","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"10.1016\/j.actbio.2021.03.062_bib0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.actbio.2016.05.005","article-title":"Thermoresponsive nanospheres with independent dual drug release profiles for the treatment of osteoarthritis","volume":"39","author":"Kang","year":"2016","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.actbio.2021.03.062_bib0071","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2006.07.022","article-title":"A thermally responsive biopolymer for intra-articular drug delivery","volume":"115","author":"Betre","year":"2006","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.actbio.2021.03.062_bib0072","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1002\/art.22952","article-title":"Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic","volume":"56","author":"Shamji","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.actbio.2021.03.062_bib0073","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.biomaterials.2018.07.011","article-title":"Cartilage repair in degenerative osteoarthritis mediated by squid type II collagen via immunomodulating activation of M2 macrophages, inhibiting apoptosis and hypertrophy of chondrocytes","volume":"180","author":"Dai","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.03.062_bib0074","doi-asserted-by":"crossref","unstructured":"Y.-R. Choi, K.H. Collins, L.E. Springer, L. Pferdehirt, A.K. Ross, C.-L. Wu, F.T. Moutos, N.S. Harasymowicz, J.M. Brunger, C.T.N. Pham, F. Guilak, A genome-engineered bioartificial implant for autoregulated anti-cytokine drug delivery, bioRxiv (2019) 535609.","DOI":"10.1101\/535609"},{"key":"10.1016\/j.actbio.2021.03.062_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2019.07.002","article-title":"Applications of RNA interference in the treatment of arthritis","volume":"214","author":"Rai","year":"2019","journal-title":"Transl. Res."},{"issue":"41","key":"10.1016\/j.actbio.2021.03.062_bib0076","doi-asserted-by":"crossref","first-page":"E6199","DOI":"10.1073\/pnas.1608245113","article-title":"Suppression of NF-kappaB activity via nanoparticle-based siRNA delivery alters early cartilage responses to injury","volume":"113","author":"Yan","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.actbio.2021.03.062_bib0077","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1172\/JCI75673","article-title":"Peptide-siRNA nanocomplexes targeting NF-kappaB subunit p65 suppress nascent experimental arthritis","volume":"124","author":"Zhou","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actbio.2021.03.062_bib0078","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2147\/IJN.S142797","article-title":"A novel therapeutic strategy for cartilage diseases based on lipid nanoparticle-RNAi delivery system","volume":"13","author":"Wang","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2021.03.062_bib0079","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fimmu.2019.00383","article-title":"Shear and dynamic compression modulates the inflammatory phenotype of human monocytes in vitro","volume":"10","author":"Fahy","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.actbio.2021.03.062_bib0080","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1089\/cell.2012.0002","article-title":"Human placenta-derived mesenchymal stem cells with silk fibroin biomaterial in the repair of articular cartilage defects","volume":"14","author":"Li","year":"2012","journal-title":"Cell Reprogram"},{"key":"10.1016\/j.actbio.2021.03.062_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111701","article-title":"Optimization of hyaluronic acid-tyramine\/silk-fibroin composite hydrogels for cartilage tissue engineering and delivery of anti-inflammatory and anabolic drugs","volume":"120","author":"Ziadlou","year":"2021","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"5","key":"10.1016\/j.actbio.2021.03.062_bib0082","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1039\/C8BM00010G","article-title":"Intra-articular TSG-6 delivery from heparin-based microparticles reduces cartilage damage in a rat model of osteoarthritis","volume":"6","author":"Tellier","year":"2018","journal-title":"Biomater. Sci."},{"issue":"10","key":"10.1016\/j.actbio.2021.03.062_bib0083","doi-asserted-by":"crossref","DOI":"10.3390\/biom10101456","article-title":"Anti-inflammatory properties of injectable betamethasone-loaded tyramine-modified gellan gum\/silk fibroin hydrogels","volume":"10","author":"Oliveira","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.actbio.2021.03.062_bib0084","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.actbio.2019.01.061","article-title":"Bioactive factors for cartilage repair and regeneration: improving delivery, retention, and activity","volume":"93","author":"Patel","year":"2019","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.actbio.2021.03.062_bib0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1517\/17425240802647259","article-title":"Intra-articular drug delivery systems: overcoming the shortcomings of joint disease therapy","volume":"6","author":"Burt","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.actbio.2021.03.062_bib0086","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11926-020-0884-z","article-title":"Nanotechnological strategies for osteoarthritis diagnosis, monitoring, clinical management, and regenerative medicine: recent advances and future opportunities","volume":"22","author":"Mohammadinejad","year":"2020","journal-title":"Curr. Rheumatol. Rep."},{"issue":"4","key":"10.1016\/j.actbio.2021.03.062_bib0087","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/1566523219666190716092203","article-title":"The therapeutic potential and role of miRNA, lncRNA, and circRNA in osteoarthritis","volume":"19","author":"Wu","year":"2019","journal-title":"Curr. Gene Ther."},{"issue":"12","key":"10.1016\/j.actbio.2021.03.062_bib0088","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/sctm.17-0181","article-title":"Biomimetic functionalization of biomaterials to stimulate the endogenous healing process of cartilage and bone tissue","volume":"6","author":"Taraballi","year":"2017","journal-title":"Stem Cells Transl. Med."},{"issue":"6","key":"10.1016\/j.actbio.2021.03.062_bib0089","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s13770-018-0135-9","article-title":"Collagen scaffolds in cartilage tissue engineering and relevant approaches for future development","volume":"15","author":"Irawan","year":"2018","journal-title":"Tissue Eng. Regen. Med."},{"issue":"1","key":"10.1016\/j.actbio.2021.03.062_bib0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/bph.14516","article-title":"Targeting the extracellular matrix for delivery of bioactive molecules to sites of arthritis","volume":"176","author":"Schultz","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.actbio.2021.03.062_bib0091","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41563-018-0190-6","article-title":"Spatial confinement downsizes the inflammatory response of macrophages","volume":"17","author":"Jain","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.actbio.2021.03.062_bib0092","article-title":"The immune system and its contribution to variability in regenerative medicine","author":"Moore","year":"2020","journal-title":"Tissue Eng. Part B Rev."},{"issue":"22","key":"10.1016\/j.actbio.2021.03.062_bib0093","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1016\/j.biomaterials.2014.03.073","article-title":"Tissue-engineered cartilage with inducible and tunable immunomodulatory properties","volume":"35","author":"Glass","year":"2014","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.actbio.2021.03.062_bib0094","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jgm.2888","article-title":"Inflammation-induced transgene expression in genetically engineered equine mesenchymal stem cells","volume":"18","author":"Gabner","year":"2016","journal-title":"J. Gene Med."},{"issue":"5","key":"10.1016\/j.actbio.2021.03.062_bib0095","doi-asserted-by":"crossref","first-page":"e3021","DOI":"10.1002\/jgm.3021","article-title":"Cytokine-induced interleukin-1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment","volume":"20","author":"Gabner","year":"2018","journal-title":"J. Gene Med."},{"key":"10.1016\/j.actbio.2021.03.062_bib0096","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49558","article-title":"Long non-coding RNA GRASLND enhances chondrogenesis via suppression of the interferon type II signaling pathway","volume":"9","author":"Huynh","year":"2020","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.actbio.2021.03.062_bib0097","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1089\/hum.2011.009","article-title":"Mesenchymal stem cell survival in the infarcted heart is enhanced by lentivirus vector-mediated heat shock protein 27 expression","volume":"24","author":"McGinley","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2021.03.062_bib0098","doi-asserted-by":"crossref","first-page":"39593","DOI":"10.1038\/srep39593","article-title":"Etanercept-synthesising mesenchymal stem cells efficiently ameliorate collagen-induced arthritis","volume":"7","author":"Park","year":"2017","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.actbio.2021.03.062_bib0099","first-page":"3603","article-title":"Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors","volume":"62","author":"Studeny","year":"2002","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.actbio.2021.03.062_bib0100","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1089\/10430340152480258","article-title":"Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo","volume":"12","author":"Bartholomew","year":"2001","journal-title":"Hum. Gene Ther."},{"issue":"9","key":"10.1016\/j.actbio.2021.03.062_bib0101","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/art.40161","article-title":"Conditional macrophage depletion increases inflammation and does not inhibit the development of osteoarthritis in obese macrophage fas-induced apoptosis-transgenic mice","volume":"69","author":"Wu","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.actbio.2021.03.062_bib0102","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.biomaterials.2015.05.028","article-title":"Macrophage repolarization with targeted alginate nanoparticles containing IL-10 plasmid DNA for the treatment of experimental arthritis","volume":"61","author":"Jain","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.03.062_bib0103","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.3389\/fimmu.2019.01998","article-title":"Nanoparticles targeting macrophages as potential clinical therapeutic agents against cancer and inflammation","volume":"10","author":"Hu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2021.03.062_bib0104","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fphar.2019.00022","article-title":"Harnessing macrophages for controlled-release drug delivery: lessons from microbes","volume":"10","author":"Visser","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"21","key":"10.1016\/j.actbio.2021.03.062_bib0105","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201900582","article-title":"Targeted delivery of siRNA lipoplexes to cancer cells using macrophage transient horizontal gene transfer","volume":"6","author":"Wayne","year":"2019","journal-title":"Adv. Sci."},{"issue":"18","key":"10.1016\/j.actbio.2021.03.062_bib0106","doi-asserted-by":"crossref","first-page":"eaaz6579","DOI":"10.1126\/sciadv.aaz6579","article-title":"Cellular backpacks for macrophage immunotherapy","volume":"6","author":"Shields","year":"2020","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.actbio.2021.03.062_bib0107","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4161\/21623945.2014.981438","article-title":"Injecting engineered anti-inflammatory macrophages therapeutically induces white adipose tissue browning and improves diet-induced insulin resistance","volume":"4","author":"Liu","year":"2015","journal-title":"Adipocyte"},{"issue":"1","key":"10.1016\/j.actbio.2021.03.062_bib0108","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/1529-0131(199901)42:1<90::AID-ANR12>3.0.CO;2-A","article-title":"Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy","volume":"42","author":"Triantaphyllopoulos","year":"1999","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.actbio.2021.03.062_bib0109","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/ard.2006.064519","article-title":"Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent","volume":"66","author":"Adriaansen","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.actbio.2021.03.062_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130612","article-title":"Preclinical potency and biodistribution studies of an AAV 5 vector expressing human interferon-beta (ART-I02) for local treatment of patients with rheumatoid arthritis","volume":"10","author":"Aalbers","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.actbio.2021.03.062_bib0111","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/gt.2012.81","article-title":"scAAV-mediated gene transfer of interleukin-1-receptor antagonist to synovium and articular cartilage in large mammalian joints","volume":"20","author":"Watson","year":"2013","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.actbio.2021.03.062_bib0112","doi-asserted-by":"crossref","first-page":"eabd9858","DOI":"10.1126\/sciadv.abd9858","article-title":"A synthetic mechanogenetic gene circuit for autonomous drug delivery in engineered tissues","volume":"7","author":"Nims","year":"2021","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.actbio.2021.03.062_bib0113","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1172\/JCI118303","article-title":"Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation","volume":"96","author":"Baragi","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.actbio.2021.03.062_bib0114","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1007\/s12274-018-2150-5","article-title":"Optimized nanoparticle-mediated delivery of CRISPR-Cas9 system for B cell intervention","volume":"11","author":"Li","year":"2018","journal-title":"Nano Res."},{"issue":"1","key":"10.1016\/j.actbio.2021.03.062_bib0115","doi-asserted-by":"crossref","first-page":"12144","DOI":"10.1038\/s41598-018-30358-0","article-title":"Engineering of primary human B cells with CRISPR\/Cas9 targeted nuclease","volume":"8","author":"Johnson","year":"2018","journal-title":"Sci. Rep."},{"issue":"44","key":"10.1016\/j.actbio.2021.03.062_bib0116","doi-asserted-by":"crossref","first-page":"12514","DOI":"10.1073\/pnas.1613884113","article-title":"Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL\/6 Cas9 transgenic mouse line","volume":"113","author":"Chu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7814","key":"10.1016\/j.actbio.2021.03.062_bib0117","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.actbio.2021.03.062_bib0118","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/annrheumdis-2020-217844","article-title":"In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells","volume":"80","author":"Zhang","year":"2021","journal-title":"Ann. Rheumat. Dis."},{"issue":"5","key":"10.1016\/j.actbio.2021.03.062_bib0119","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/art.39982","article-title":"CRISPR\/Cas9 editing of murine induced pluripotent stem cells for engineering inflammation-resistant tissues","volume":"69","author":"Brunger","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.actbio.2021.03.062_bib0120","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.stemcr.2017.03.022","article-title":"Genome engineering of stem cells for autonomously regulated, closed-loop delivery of biologic drugs","volume":"8","author":"Brunger","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"117","key":"10.1016\/j.actbio.2021.03.062_bib0121","doi-asserted-by":"crossref","DOI":"10.3791\/54720","article-title":"Development of stem cell-derived antigen-specific regulatory T cells against autoimmunity","author":"Haque","year":"2016","journal-title":"J. Vis. Exp."},{"issue":"30","key":"10.1016\/j.actbio.2021.03.062_bib0122","doi-asserted-by":"crossref","first-page":"eaba6884","DOI":"10.1126\/sciadv.aba6884","article-title":"Shattering barriers toward clinically meaningful MSC therapies","volume":"6","author":"Levy","year":"2020","journal-title":"Sci. Adv."},{"issue":"19","key":"10.1016\/j.actbio.2021.03.062_bib0123","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96260","article-title":"Delivery of monocyte lineage cells in a biomimetic scaffold enhances tissue repair","volume":"2","author":"Hu","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.actbio.2021.03.062_bib0124","doi-asserted-by":"crossref","first-page":"e2062","DOI":"10.1038\/cddis.2015.327","article-title":"Mesenchymal stem cells and immunomodulation: current status and future prospects","volume":"7","author":"Gao","year":"2016","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.actbio.2021.03.062_bib0125","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00296-019-04296-7","article-title":"Secretory factors produced by adipose mesenchymal stem cells downregulate Th17 and increase Treg cells in peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"39","author":"Vasilev","year":"2019","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.actbio.2021.03.062_bib0126","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/wound.2011.0314","article-title":"Mesenchymal stem cells home to sites of injury and inflammation","volume":"1","author":"Rustad","year":"2012","journal-title":"Adv. Wound Care"},{"issue":"8","key":"10.1016\/j.actbio.2021.03.062_bib0127","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081852","article-title":"Mesenchymal Stem\/stromal cells for rheumatoid arthritis treatment: an update on clinical applications","volume":"9","author":"Lopez-Santalla","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.actbio.2021.03.062_bib0128","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/jor.24343","article-title":"MSC therapy for osteoarthritis: an unfinished story","volume":"37","author":"Barry","year":"2019","journal-title":"J. Orthop. Res."},{"issue":"1","key":"10.1016\/j.actbio.2021.03.062_bib0129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13287-017-0511-8","article-title":"CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?","volume":"8","author":"Gerace","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.actbio.2021.03.062_bib0130","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.587776","article-title":"Enhancement of the therapeutic capacity of mesenchymal stem cells by genetic modification: a systematic review","volume":"8","author":"Pawitan","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.actbio.2021.03.062_bib0131","doi-asserted-by":"crossref","first-page":"34","DOI":"10.21037\/sci.2019.08.11","article-title":"A revealing review of mesenchymal stem cells therapy, clinical perspectives and Modification strategies","volume":"6","author":"Saeedi","year":"2019","journal-title":"Stem Cell Investig."},{"key":"10.1016\/j.actbio.2021.03.062_bib0132","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","article-title":"Molecular mechanisms that influence the macrophage m1-m2 polarization balance","volume":"5","author":"Wang","year":"2014","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.actbio.2021.03.062_bib0133","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41374-019-0334-6","article-title":"Role of macrophage TRPV4 in inflammation","volume":"100","author":"Dutta","year":"2020","journal-title":"Lab. Invest."},{"issue":"6","key":"10.1016\/j.actbio.2021.03.062_bib0134","first-page":"5009","article-title":"Imbalance of M1\/M2 macrophages is linked to severity level of knee osteoarthritis","volume":"16","author":"Liu","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"18","key":"10.1016\/j.actbio.2021.03.062_bib0135","doi-asserted-by":"crossref","first-page":"eaay6391","DOI":"10.1126\/sciadv.aay6391","article-title":"Macrophages of diverse phenotypes drive vascularization of engineered tissues","volume":"6","author":"Graney","year":"2020","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.actbio.2021.03.062_bib0136","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1172\/JCI124615","article-title":"The role of macrophages in the resolution of inflammation","volume":"129","author":"Watanabe","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.actbio.2021.03.062_bib0137","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071545","article-title":"Macrophage phenotypes regulate scar formation and chronic wound healing","volume":"18","author":"Hesketh","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.actbio.2021.03.062_bib0138","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nri.2017.42","article-title":"Does niche competition determine the origin of tissue-resident macrophages?","volume":"17","author":"Guilliams","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actbio.2021.03.062_bib0139","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1583647","article-title":"Synovial macrophages in rheumatoid arthritis: the past, present, and future","volume":"2020","author":"Tu","year":"2020","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.actbio.2021.03.062_bib0140","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/s12891-019-2977-2","article-title":"Parallel comparison of fibroblast-like synoviocytes from the surgically removed hyperplastic synovial tissues of rheumatoid arthritis and osteoarthritis patients","volume":"20","author":"Huang","year":"2019","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.actbio.2021.03.062_bib0141","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3389\/fimmu.2018.01924","article-title":"T cells that help B cells in chronically inflamed tissues","volume":"9","author":"Rao","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2021.03.062_bib0142","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/bs.pmbts.2015.07.021","article-title":"Regulatory T cells in arthritis","volume":"136","author":"Komatsu","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"3","key":"10.1016\/j.actbio.2021.03.062_bib0143","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/08923973.2018.1437625","article-title":"CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis","volume":"40","author":"Safari","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"6","key":"10.1016\/j.actbio.2021.03.062_bib0144","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nm.4324","article-title":"Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment","volume":"23","author":"Jeon","year":"2017","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.actbio.2021.03.062_bib0145","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41598-018-37448-z","article-title":"High percentages and activity of synovial fluid NK cells present in patients with advanced stage active rheumatoid arthritis","volume":"9","author":"Yamin","year":"2019","journal-title":"Sci. Rep."},{"issue":"47","key":"10.1016\/j.actbio.2021.03.062_bib0146","doi-asserted-by":"crossref","first-page":"19172","DOI":"10.1073\/pnas.1210422109","article-title":"Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells","volume":"109","author":"Diekman","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.actbio.2021.03.062_bib0147","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1002\/art.38780","article-title":"Use of cartilage derived from murine induced pluripotent stem cells for osteoarthritis drug screening","volume":"66","author":"Willard","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.actbio.2021.03.062_bib0148","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1089\/ten.tea.2019.0027","article-title":"A synthetic gene circuit for self-regulating delivery of biologic drugs in engineered tissues","volume":"25","author":"Lara Pferdehirt","year":"2019","journal-title":"Tissue Eng. Part A"},{"issue":"3","key":"10.1016\/j.actbio.2021.03.062_bib0149","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.1200633","article-title":"Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity","volume":"189","author":"Haque","year":"2012","journal-title":"J. Immunol."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706121002129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706121002129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:46:40Z","timestamp":1761673600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706121002129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":149,"alternative-id":["S1742706121002129"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2021.03.062","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoengineering the next generation of arthritis therapies","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2021.03.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}